Cancer treatment in determination of hearing loss
ABSTRACT INTRODUCTION: Chemotherapy and radiotherapy in oncology have repercussions in hearing health, and can damage structures of the inner ear. These repercussions usually, result in a bilateral and irreversible hearing loss. OBJECTIVE: To identify sensorineural hearing loss cases with compla...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2016-02-01
|
| Series: | Brazilian Journal of Otorhinolaryngology |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1808-86942016000100065&lng=en&tlng=en |
| _version_ | 1830298538415751168 |
|---|---|
| author | Priscila Feliciano de Oliveira Camila Silva Oliveira Joice Santos Andrade Tamara Figueiredo do Carmo Santos Aline Cabral de Oliveira-Barreto |
| author_facet | Priscila Feliciano de Oliveira Camila Silva Oliveira Joice Santos Andrade Tamara Figueiredo do Carmo Santos Aline Cabral de Oliveira-Barreto |
| author_sort | Priscila Feliciano de Oliveira |
| collection | DOAJ |
| description | ABSTRACT INTRODUCTION: Chemotherapy and radiotherapy in oncology have repercussions in hearing health, and can damage structures of the inner ear. These repercussions usually, result in a bilateral and irreversible hearing loss. OBJECTIVE: To identify sensorineural hearing loss cases with complaints of tinnitus and difficulty in speech understanding and investigate their relationship with the types of chemotherapy and radiotherapy the patients received. METHODS: Cross-sectional, clinical, observational, analytical, historical cohort study of 58 subjects treated in a public hospital in the state of Sergipe, diagnosed with neoplasia. The subjects were submitted to anamnesis, conventional pure tone audiometry, and speech recognition threshold. RESULTS: Of the 116 ears, 25.9% presented sensorioneural hearing loss characterized by changes in high frequencies. There was a positive correlation between hearing loss and the association of chemotherapy and radiotherapy ( p = 0.035; R = 0.196). The auditory complaint analysis shows that most of the subjects had tinnitus and speech understanding difficulty, even with a normal auditory threshold. CONCLUSIONS: Cancer treatment causes hearing loss, associated with the administration of chemotherapy and radiotherapy. Cyclophosphamide increased the risk of causing hearing loss. Complaints of tinnitus and speech understanding difficulty were observed. |
| first_indexed | 2024-12-19T07:52:44Z |
| format | Article |
| id | doaj.art-6de78389f771469d992661507203afec |
| institution | Directory Open Access Journal |
| issn | 1808-8686 |
| language | English |
| last_indexed | 2024-12-19T07:52:44Z |
| publishDate | 2016-02-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Brazilian Journal of Otorhinolaryngology |
| spelling | doaj.art-6de78389f771469d992661507203afec2022-12-21T20:30:05ZengElsevierBrazilian Journal of Otorhinolaryngology1808-86862016-02-01821656910.1016/j.bjorl.2014.12.010S1808-86942016000100065Cancer treatment in determination of hearing lossPriscila Feliciano de OliveiraCamila Silva OliveiraJoice Santos AndradeTamara Figueiredo do Carmo SantosAline Cabral de Oliveira-BarretoABSTRACT INTRODUCTION: Chemotherapy and radiotherapy in oncology have repercussions in hearing health, and can damage structures of the inner ear. These repercussions usually, result in a bilateral and irreversible hearing loss. OBJECTIVE: To identify sensorineural hearing loss cases with complaints of tinnitus and difficulty in speech understanding and investigate their relationship with the types of chemotherapy and radiotherapy the patients received. METHODS: Cross-sectional, clinical, observational, analytical, historical cohort study of 58 subjects treated in a public hospital in the state of Sergipe, diagnosed with neoplasia. The subjects were submitted to anamnesis, conventional pure tone audiometry, and speech recognition threshold. RESULTS: Of the 116 ears, 25.9% presented sensorioneural hearing loss characterized by changes in high frequencies. There was a positive correlation between hearing loss and the association of chemotherapy and radiotherapy ( p = 0.035; R = 0.196). The auditory complaint analysis shows that most of the subjects had tinnitus and speech understanding difficulty, even with a normal auditory threshold. CONCLUSIONS: Cancer treatment causes hearing loss, associated with the administration of chemotherapy and radiotherapy. Cyclophosphamide increased the risk of causing hearing loss. Complaints of tinnitus and speech understanding difficulty were observed.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1808-86942016000100065&lng=en&tlng=enNeoplasiaPerda auditivaQuimioterapiaRadioterapia |
| spellingShingle | Priscila Feliciano de Oliveira Camila Silva Oliveira Joice Santos Andrade Tamara Figueiredo do Carmo Santos Aline Cabral de Oliveira-Barreto Cancer treatment in determination of hearing loss Brazilian Journal of Otorhinolaryngology Neoplasia Perda auditiva Quimioterapia Radioterapia |
| title | Cancer treatment in determination of hearing loss |
| title_full | Cancer treatment in determination of hearing loss |
| title_fullStr | Cancer treatment in determination of hearing loss |
| title_full_unstemmed | Cancer treatment in determination of hearing loss |
| title_short | Cancer treatment in determination of hearing loss |
| title_sort | cancer treatment in determination of hearing loss |
| topic | Neoplasia Perda auditiva Quimioterapia Radioterapia |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1808-86942016000100065&lng=en&tlng=en |
| work_keys_str_mv | AT priscilafelicianodeoliveira cancertreatmentindeterminationofhearingloss AT camilasilvaoliveira cancertreatmentindeterminationofhearingloss AT joicesantosandrade cancertreatmentindeterminationofhearingloss AT tamarafigueiredodocarmosantos cancertreatmentindeterminationofhearingloss AT alinecabraldeoliveirabarreto cancertreatmentindeterminationofhearingloss |